{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:15:43Z","timestamp":1783019743703,"version":"3.54.6"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic cancer (PC) is a highly malignant tumor with increasing incidence, mortality, and a low five-year survival rate. Mitochondrial metabolic reprogramming plays a crucial role in tumor development, but the molecular mechanisms in different cell subpopulations of PC remain unclear. This study aims to integrate single-cell RNA sequencing (scRNA-seq) and bulk RNA-seq to explore mitochondrial metabolism in PC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Transcriptome datasets (GSE183795, GSE16515, GSE197177, and TCGA-PAAD) were downloaded from the GEO and TCGA databases. Differentially expressed genes (DEGs) were identified using the limma package for bulk RNA-seq and the Seurat package for scRNA-seq. Weighted gene co-expression network analysis (WGCNA) was performed to identify key modules and hub genes. Machine learning algorithms screened key genes, and functional enrichment analysis was conducted using clusterProfiler. PPI, ceRNA, and transcription factor networks explored gene regulation. Immune infiltration analysis, drug prediction, and molecular docking were conducted on key genes. The prognostic value of the key genes was evaluated using clinical data from TCGA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1238 bulk RNA-DEGs and 8231 scRNA-DEGs in fibroblasts were identified. Integration of both datasets revealed 536 DEGs. WGCNA identified 6 modules associated with PC. By intersecting DEGs, hub genes, and mitochondrial metabolism-related genes, 18 candidate genes were obtained. These genes were enriched in glucose metabolism and mitochondrial outer membrane pathways. Three key genes (IFI27, PKM, and RSAD2) were selected using machine learning. PPI, ceRNA, and transcription factor networks provided regulatory insights. Immune infiltration analysis showed significant differences in immune cells, particularly in T cells CD4 memory resting and macrophages M2. Drug prediction and molecular docking identified potential drugs for these genes. Survival analysis indicated that high expression of these genes correlated with poor prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study integrates scRNA-seq and bulk RNA-seq data to identify three key genes (IFI27, PKM, and RSAD2) and their immune-related mechanisms in PC. These findings offer new insights into the pathogenesis and potential therapeutic targets for PC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0351701","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:59:23Z","timestamp":1783015163000},"page":"e0351701","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Key molecular mechanisms of mitochondrial metabolic pathways in specific cell subpopulations of pancreatic cancer based on scRNA-seq and bulk RNA-seq"],"prefix":"10.1371","volume":"21","author":[{"given":"Jianping","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6153-0550","authenticated-orcid":true,"given":"Xingjian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"issue":"3","key":"pone.0351701.ref001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"H Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"pone.0351701.ref002","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000477773","article-title":"Tumor heterogeneity in pancreatic adenocarcinoma","volume":"85","author":"J Cros","year":"2018","journal-title":"Pathobiology"},{"key":"pone.0351701.ref003","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.2147\/IJN.S413496","article-title":"Advances and prospects in the treatment of pancreatic cancer","volume":"18","author":"H Duan","year":"2023","journal-title":"Int J Nanomedicine"},{"issue":"6","key":"pone.0351701.ref004","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11061611","article-title":"Therapeutic approaches in pancreatic cancer: recent updates","volume":"11","author":"L Kumar","year":"2023","journal-title":"Biomedicines"},{"issue":"9","key":"pone.0351701.ref005","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.3390\/cancers15092482","article-title":"Significance of tumor microenvironment for regulating pancreatic cancer","volume":"15","author":"H Ijichi","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"6","key":"pone.0351701.ref006","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3892\/ol.2023.13847","article-title":"Distribution characteristics and clinical significance of infiltrating T cells in the tumor microenvironment of pancreatic cancer","volume":"25","author":"G Sun","year":"2023","journal-title":"Oncol Lett"},{"issue":"46","key":"pone.0351701.ref007","doi-asserted-by":"crossref","first-page":"7956","DOI":"10.3748\/wjg.v27.i46.7956","article-title":"T cells in pancreatic cancer stroma","volume":"27","author":"MR Goulart","year":"2021","journal-title":"World J Gastroenterol"},{"key":"pone.0351701.ref008","doi-asserted-by":"crossref","first-page":"117430","DOI":"10.1016\/j.biopha.2024.117430","article-title":"Advances of immune-checkpoint inhibition of CTLA-4 in pancreatic cancer","volume":"179","author":"R Ni","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"pone.0351701.ref009","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5114\/pjp.2023.132220","article-title":"Prognostic significance of PD-L1 expression in pancreatic cancer: evidence from an updated meta-analysis","volume":"74","author":"C Liu","year":"2023","journal-title":"Pol J Pathol"},{"issue":"5","key":"pone.0351701.ref010","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jcmgh.2024.01.022","article-title":"Rethinking the roles of cancer-associated fibroblasts in pancreatic cancer","volume":"17","author":"R Francescone","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"6","key":"pone.0351701.ref011","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.molmed.2023.03.002","article-title":"Fibroblasts in pancreatic cancer: molecular and clinical perspectives","volume":"29","author":"R Rebelo","year":"2023","journal-title":"Trends Mol Med"},{"issue":"1","key":"pone.0351701.ref012","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/cancers15010061","article-title":"Cancer-associated fibroblast diversity shapes tumor metabolism in pancreatic cancer","volume":"15","author":"R Peiffer","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"pone.0351701.ref013","doi-asserted-by":"crossref","first-page":"12028","DOI":"10.1038\/s41598-024-62498-x","article-title":"The serum tenascin C level is a marker of metabolic disorder-related inflammation affecting pancreatic cancer prognosis","volume":"14","author":"K Sato","year":"2024","journal-title":"Sci Rep"},{"issue":"3","key":"pone.0351701.ref014","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCRESAHA.120.316958","article-title":"Myofibroblasts and fibrosis: mitochondrial and metabolic control of cellular differentiation","volume":"127","author":"AA Gibb","year":"2020","journal-title":"Circ Res"},{"issue":"4","key":"pone.0351701.ref015","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3390\/cancers15041070","article-title":"Mitochondrial metabolism in pancreatic ductal adenocarcinoma: from mechanism-based perspectives to therapy","volume":"15","author":"H Padinharayil","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"17","key":"pone.0351701.ref016","doi-asserted-by":"crossref","first-page":"8322","DOI":"10.7150\/thno.62378","article-title":"Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming","volume":"11","author":"Z Li","year":"2021","journal-title":"Theranostics"},{"issue":"3","key":"pone.0351701.ref017","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/mco2.37","article-title":"The biological role of metabolic reprogramming in pancreatic cancer","volume":"1","author":"T Suzuki","year":"2020","journal-title":"MedComm (2020)"},{"issue":"16","key":"pone.0351701.ref018","doi-asserted-by":"crossref","first-page":"12787","DOI":"10.3390\/ijms241612787","article-title":"Integration of single-cell RNA sequencing and bulk RNA sequencing reveals that TAM2-driven genes affect immunotherapeutic response and prognosis in pancreatic cancer","volume":"24","author":"Y Du","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"pone.0351701.ref019","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5483\/BMBRep.2017.50.6.086","article-title":"Single-cell RNA-Seq unveils tumor microenvironment","volume":"50","author":"H-O Lee","year":"2017","journal-title":"BMB Rep"},{"issue":"7","key":"pone.0351701.ref020","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.pan.2022.08.007","article-title":"Integrative transcriptomic analysis identifies a novel gene signature to predict prognosis of pancreatic cancer in different subtypes","volume":"22","author":"CY Li","year":"2022","journal-title":"Pancreatology"},{"issue":"11","key":"pone.0351701.ref021","first-page":"1791","article-title":"Weighted gene co-expression network analysis in biomedicine research","volume":"33","author":"W Liu","year":"2017","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"issue":"1","key":"pone.0351701.ref022","article-title":"Machine learning meets omics: applications and perspectives","volume":"23","author":"R Li","year":"2022","journal-title":"Brief Bioinform"},{"issue":"1","key":"pone.0351701.ref023","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12967-023-04033-6","article-title":"Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma","volume":"21","author":"J Chang","year":"2023","journal-title":"J Transl Med"},{"issue":"5","key":"pone.0351701.ref024","article-title":"Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer","volume":"42","author":"N Niu","year":"2024","journal-title":"Cancer Cell"},{"issue":"10242","key":"pone.0351701.ref025","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"JD Mizrahi","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"pone.0351701.ref026","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s10555-021-10004-4","article-title":"Metabolic reprogramming by driver mutation-tumor microenvironment interplay in pancreatic cancer: new therapeutic targets","volume":"40","author":"HB Andersen","year":"2021","journal-title":"Cancer Metastasis Rev"},{"issue":"10","key":"pone.0351701.ref027","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41419-022-05351-1","article-title":"Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma","volume":"13","author":"T Zhang","year":"2022","journal-title":"Cell Death Dis"},{"issue":"3","key":"pone.0351701.ref028","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/metabo13030345","article-title":"The role of reprogrammed glucose metabolism in cancer","volume":"13","author":"MK Ediriweera","year":"2023","journal-title":"Metabolites"},{"issue":"7","key":"pone.0351701.ref029","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/cac2.12549","article-title":"The regulatory roles and clinical significance of glycolysis in tumor","volume":"44","author":"Q Qiao","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"pone.0351701.ref030","doi-asserted-by":"crossref","first-page":"1044585","DOI":"10.3389\/fmmed.2022.1044585","article-title":"Acetyl-CoA: an interplay between metabolism and epigenetics in cancer","volume":"2","author":"Y Hao","year":"2022","journal-title":"Front Mol Med"},{"key":"pone.0351701.ref031","doi-asserted-by":"crossref","first-page":"1272646","DOI":"10.3389\/fendo.2023.1272646","article-title":"Novel insights into the role of acetyl-CoA producing enzymes in epigenetic regulation","volume":"14","author":"M Russo","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"pone.0351701.ref032","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41420-024-01805-x","article-title":"\u03b1-Ketoglutarate supplementation and NAD+ modulation enhance metabolic rewiring and radiosensitization in SLC25A1 inhibited cancer cells","volume":"10","author":"K Xiang","year":"2024","journal-title":"Cell Death Discov"},{"issue":"6","key":"pone.0351701.ref033","article-title":"The role of type 2 diabetes in pancreatic cancer","volume":"14","author":"S George","year":"2022","journal-title":"Cureus"},{"key":"pone.0351701.ref034","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbrc.2023.01.061","article-title":"Insulin promotes the proliferation and migration of pancreatic cancer cells by up-regulating the expression of PLK1 through the PI3K\/AKT pathway","volume":"648","author":"K Wu","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"pone.0351701.ref035","doi-asserted-by":"crossref","first-page":"8515","DOI":"10.1080\/21655979.2021.1985858","article-title":"Interferon alpha-inducible protein 27 (IFI27) is a prognostic marker for pancreatic cancer based on comprehensive bioinformatics analysis","volume":"12","author":"S Huang","year":"2021","journal-title":"Bioengineered"},{"key":"pone.0351701.ref036","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.canlet.2020.11.018","article-title":"Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics","volume":"503","author":"S Zhu","year":"2021","journal-title":"Cancer Lett"},{"issue":"12","key":"pone.0351701.ref037","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41419-019-2073-4","article-title":"Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2\/AMPK\/mTOC1 pathway","volume":"10","author":"Q Xu","year":"2019","journal-title":"Cell Death Dis"},{"issue":"2","key":"pone.0351701.ref038","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13105-024-01007-0","article-title":"The role of PKM2 in cancer progression and its structural and biological basis","volume":"80","author":"B Wu","year":"2024","journal-title":"J Physiol Biochem"},{"issue":"2","key":"pone.0351701.ref039","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s10753-024-02076-5","article-title":"Crucial roles of RSAD2\/viperin in immunomodulation, mitochondrial metabolism and autoimmune diseases","volume":"48","author":"S Chen","year":"2025","journal-title":"Inflammation"},{"issue":"1","key":"pone.0351701.ref040","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/jcp.28980","article-title":"Weighted gene correlation network analysis identifies RSAD2, HERC5, and CCL8 as prognostic candidates for breast cancer","volume":"235","author":"J Tang","year":"2020","journal-title":"J Cell Physiol"},{"issue":"9","key":"pone.0351701.ref041","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00011-024-01907-3","article-title":"Dissection of pro-tumoral macrophage subtypes and immunosuppressive cells participating in M2 polarization","volume":"73","author":"O Sezginer","year":"2024","journal-title":"Inflamm Res"},{"issue":"13","key":"pone.0351701.ref042","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"AJ Boutilier","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0351701.ref043","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009930","article-title":"Arginase-1-specific T cells target and modulate tumor-associated macrophages","volume":"13","author":"E Martinenaite","year":"2025","journal-title":"J Immunother Cancer"},{"key":"pone.0351701.ref044","doi-asserted-by":"crossref","first-page":"122943","DOI":"10.1016\/j.biomaterials.2024.122943","article-title":"Engineering M2 macrophage-derived exosomes modulate activated T cell cuproptosis to promote immune tolerance in rheumatoid arthritis","volume":"315","author":"G Wu","year":"2025","journal-title":"Biomaterials"},{"issue":"1","key":"pone.0351701.ref045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41391-024-00797-0","article-title":"Natural killer cell infiltration in prostate cancers predict improved patient outcomes","volume":"28","author":"NA Zorko","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"pone.0351701.ref046","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pros.24068","article-title":"High intratumoral CD8+ T-cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy","volume":"81","author":"Y Yang","year":"2021","journal-title":"Prostate"},{"issue":"1","key":"pone.0351701.ref047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tips.2021.11.003","article-title":"Engineering T cell memory for antitumor immunity","volume":"43","author":"AM Bhuiyan","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"pone.0351701.ref048","doi-asserted-by":"crossref","first-page":"1193610","DOI":"10.3389\/fphar.2023.1193610","article-title":"Hypoglycemic agents and incidence of pancreatic cancer in diabetic patients: a meta-analysis","volume":"14","author":"Z Zhao","year":"2023","journal-title":"Front Pharmacol"},{"issue":"13","key":"pone.0351701.ref049","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.3390\/ijms21134721","article-title":"The specific IKK\u03b5\/TBK1 inhibitor amlexanox suppresses human melanoma by the inhibition of autophagy, NF-\u03baB and MAP kinase pathways","volume":"21","author":"M M\u00f6ller","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"pone.0351701.ref050","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1152\/physrev.00047.2011","article-title":"S-adenosylmethionine in liver health, injury, and cancer","volume":"92","author":"SC Lu","year":"2012","journal-title":"Physiol Rev"},{"issue":"4","key":"pone.0351701.ref051","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tranon.2017.04.009","article-title":"The role of fibroblasts in pancreatic cancer: extracellular matrix versus paracrine factors","volume":"10","author":"L Bolm","year":"2017","journal-title":"Transl Oncol"},{"issue":"10","key":"pone.0351701.ref052","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/jth.15794","article-title":"Breast cancer cells mediate endothelial cell activation, promoting von Willebrand factor release, tumor adhesion, and transendothelial migration","volume":"20","author":"SPS Dhami","year":"2022","journal-title":"J Thromb Haemost"},{"key":"pone.0351701.ref053","doi-asserted-by":"crossref","first-page":"1367875","DOI":"10.3389\/fimmu.2024.1367875","article-title":"Endothelial cells in tumor microenvironment: insights and perspectives","volume":"15","author":"P Leone","year":"2024","journal-title":"Front Immunol"},{"issue":"6","key":"pone.0351701.ref054","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2024.07.016","article-title":"Cancer-Associated Endocrine Cells Participate in Pancreatic Carcinogenesis","volume":"167","author":"Y Chen","year":"2024","journal-title":"Gastroenterology"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0351701","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:59:30Z","timestamp":1783015170000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0351701"}},"subtitle":[],"editor":[{"given":"Zeyneb","family":"Kurt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0351701","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]}}}